XVIVO Presents Interim Report January-September 2021

GOTHENBURG, SE / ACCESSWIRE / October 21, 2021 / XVIVO Perfusion AB (STO:XVIVO)(LSE:0RKL)(FRA:3XV)Third quarter 2021 (Jul 1 - Sep 30)• Net sales amounted to SEK 54.9 million (42.7), corresponding to an increase of 29 percent in SEK and 31 percent in …